Robotic Surgery in Oncology: Is the "Autonomous Surgeon" the Key to Zero-Margin Resections?
In 2026, the global Soft Tissue Sarcoma Market is being disrupted by "AI-Guided Robotics." When removing a sarcoma, the "Margin"—the healthy tissue around the tumor—is everything; if even one cell is left behind, the cancer returns. This year, new robotic platforms are using "Fluorescence-Guided Imaging" to make cancer cells glow bright green under a specialized camera, allowing the...
0 Yorumlar 0 hisse senetleri 21 Views 0 önizleme
JogaJog https://jogajog.com.bd